Dobak John 4
4 · DermTech, Inc. · Filed Mar 9, 2022
Insider Transaction Report
Form 4
DermTech, Inc.DMTK
Dobak John
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2022-03-07$13.03/sh−2,561$33,370→ 448,661 total - Sale
Common Stock
2022-03-08$12.64/sh−786$9,935→ 447,875 total
Footnotes (3)
- [F1]The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on March 29, 2021.
- [F2]Includes 660 shares acquired under the Issuer's Employee Stock Purchase Plan on February 28, 2022.
- [F3]The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on January 17, 2020.